TrialProstate cancer and prostatic diseases2016

A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomy.

A J Armstrong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.